TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...

TAMPA, Fla. and LONDON, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads, ...

Non-terrestrial networks, combined with early 6G research, demand test equipment capable of handling extreme parameters and ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads, today ...

In this article, we examine ongoing challenges shaping target-based drug discovery and highlight how new technologies and ...

Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments December 16, 2025 11:15 AM ...

Could the first confirmed signal from an extraterrestrial source be less a hello than a goodbye? Astrophysicist David Kipping ...

Mars looks quiet today, but new research suggests the planet’s surface still carries the rhythm of a vanished companion.

This study presents an elliptical retarder model, enhancing polarization analysis and offering a robust framework for ...

Using a diamond as a quantum simulator, scientists created a rondeau time crystal, which exhibited both long-range temporal ...

Over the past decades, engineers have introduced numerous technologies that rely on light and its underlying characteristics. These include photonic and quantum systems that could advance imaging, ...